Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome
Lubka T. Roumenina, Mathieu Jablonski, Christophe Hue et al. · Blood · 2009
Complement is a major innate immune defense against pathogens, tightly regulated to prevent host tissue damage. Atypical hemolytic uremic syndrome (aHUS) is characterized by endothelial damage leading to renal failure and is highly associated with abnormal alternative pathway regulation. We characterized the functional consequences of 2 aHUS-associated mutations (D(254)G and K(325)N) in factor B, a key participant in the alternative C3 convertase. Mutant proteins formed high-affinity C3-binding site, leading to a hyperfunctional C3 convertase, resistant to decay by factor H. This led to enhanced complement deposition on the surface of alternative pathway activator cells. In contrast to native factor B, the 2 mutants bound to inactivated C3 and induced formation of functional C3-convertase on iC3b-coated surface. We demonstrated for the first time that factor B mutations lead to enhanced C3-fragment deposition on quiescent and adherent human glomerular cells (GEnCs) and human umbilical vein endothelial cells (HUVECs), together with the formation of sC5b-9 complexes. These results could explain the occurrence of the disease, since excessive complement deposition on endothelial cells is a central event in the pathogenesis of aHUS. Therefore, risk factors for aHUS are not only mutations leading to loss of regulation, but also mutations, resulting in hyperactive C3 convertase.
Cited by 157 works. doi:10.1182/blood-2009-01-197640 Open-access PDF
Authors
- Lubka T. Roumenina
- Mathieu Jablonski
- Christophe Hue
- Jacques Blouin
- Jordan D. Dimitrov
- Marie‐Agnès Dragon‐Durey
- Mathieu Cayla
- Wolf H. Fridman
- Marie‐Alice Macher
- David Ribes
- Luc Moulonguet
- Lionel P. E. Rostaing
- Simon C. Satchell
- Peter William Mathieson
- Catherine Sautès‐Fridman
- Chantal Loirat
- Catherine H. Régnier
- Lise Halbwachs‐Mecarelli
- Véronique Frémeaux‐Bacchi
References
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIA
- Anesthesiology
- Complement
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
- Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
- Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome
- Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic Syndrome
- Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
- Complement and coagulation: strangers or partners in crime?